Immunic Inc
IMUX0.978USD
+0.047+5.01%
收盤 08/04, 16:00（美東）報價延遲15分鐘
88.19M總市值
虧損本益比TTM
關於 Immunic Inc 公司
Immunic, Inc. 是一家生物技術公司。該公司專注於開發用於治療慢性炎症和自身免疫性疾病的口服小分子療法的臨牀產品線。該公司的主導開發項目 vidofludimus calcium (IMU-838) 分別處於治療複發性和進行性多發性硬化症的 III 期和 II 期臨牀試驗階段，並在 II 期臨牀試驗中顯示出對復發緩解型多發性硬化症、進行性多發性硬化症和中度至重度潰瘍性結腸炎患者的治療效果。IMU-856 靶向蛋白質 Sirtuin 6 (SIRT6)，旨在恢復腸道屏障功能並再生腸道上皮，這可能適用於多種胃腸道疾病，例如乳糜瀉。IMU-381 處於臨牀前測試階段，這是一種正在開發的下一代分子，專門用於滿足胃腸道疾病的需求。
公司簡介
公司代碼IMUX
公司名稱Immunic Inc
上市日期Apr 17, 2014
CEODr. Daniel Vitt, Ph.D.
員工數量91
證券類型Ordinary Share
年結日Apr 17
公司地址1200 Avenue Of The Americas
城市NEW YORK
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編10036
電話13322559818
網址https://imux.com/
公司代碼IMUX
上市日期Apr 17, 2014
CEODr. Daniel Vitt, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Daniel Vitt, Ph.D.
Dr. Daniel Vitt, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
391.88K
+3.98%
Dr. Joerg Neermann, Ph.D.
Dr. Joerg Neermann, Ph.D.
Independent Director
Independent Director
200.00K
+100.00%
Mr. Glenn Whaley, CPA
Mr. Glenn Whaley, CPA
Chief Financial Officer
Chief Financial Officer
95.51K
+89.09%
Dr. Duane D. Nash, M.D.
Dr. Duane D. Nash, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
42.03K
+90.78%
Mr. Jason Tardio
Mr. Jason Tardio
President, Chief Operating Officer
President, Chief Operating Officer
12.51K
--
Ms. Simona Skerjanec, M.D.
Ms. Simona Skerjanec, M.D.
Independent Director
Independent Director
--
--
Dr. Andreas Muehler, M.D.
Dr. Andreas Muehler, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Inderpal Singh
Mr. Inderpal Singh
General Counsel
General Counsel
--
--
Ms. Maria Toernsen
Ms. Maria Toernsen
Independent Director
Independent Director
--
--
Dr. Hella Kohlhof, Ph.D.
Dr. Hella Kohlhof, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Daniel Vitt, Ph.D.
Dr. Daniel Vitt, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
391.88K
+3.98%
Dr. Joerg Neermann, Ph.D.
Dr. Joerg Neermann, Ph.D.
Independent Director
Independent Director
200.00K
+100.00%
Mr. Glenn Whaley, CPA
Mr. Glenn Whaley, CPA
Chief Financial Officer
Chief Financial Officer
95.51K
+89.09%
Dr. Duane D. Nash, M.D.
Dr. Duane D. Nash, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
42.03K
+90.78%
Mr. Jason Tardio
Mr. Jason Tardio
President, Chief Operating Officer
President, Chief Operating Officer
12.51K
--
Ms. Simona Skerjanec, M.D.
Ms. Simona Skerjanec, M.D.
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
BVF Partners L.P.
9.29%
abrdn Inc.
8.60%
Soleus Capital Management, L.P.
7.61%
Avidity Partners Management LP
4.65%
The Vanguard Group, Inc.
4.10%
Other
65.74%
持股股東
持股股東
佔比
BVF Partners L.P.
9.29%
abrdn Inc.
8.60%
Soleus Capital Management, L.P.
7.61%
Avidity Partners Management LP
4.65%
The Vanguard Group, Inc.
4.10%
Other
65.74%
股東類型
持股股東
佔比
Hedge Fund
26.20%
Investment Advisor
13.30%
Investment Advisor/Hedge Fund
11.31%
Individual Investor
1.36%
Research Firm
1.05%
Pension Fund
0.06%
Other
46.74%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
135
51.29M
53.53%
-8.04M
2025Q1
143
43.91M
45.87%
-16.90M
2024Q4
141
54.47M
60.46%
-15.06M
2024Q3
152
61.42M
68.19%
-8.79M
2024Q2
169
63.34M
74.84%
-9.30M
2024Q1
202
64.86M
76.52%
-3.93M
2023Q4
199
22.30M
46.89%
-13.27M
2023Q3
205
25.26M
53.96%
-11.93M
2023Q2
209
27.09M
58.47%
-12.08M
2023Q1
208
31.66M
68.86%
-6.82M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BVF Partners L.P.
8.90M
9.29%
--
--
Mar 31, 2025
abrdn Inc.
1.06M
1.11%
+1.06M
--
Mar 31, 2025
Soleus Capital Management, L.P.
7.29M
7.61%
--
--
Mar 31, 2025
Avidity Partners Management LP
4.45M
4.65%
-3.51M
-44.09%
Mar 31, 2025
The Vanguard Group, Inc.
3.93M
4.1%
+7.79K
+0.20%
Mar 31, 2025
Focus Partners Wealth, LLC
2.58M
2.7%
+415.10K
+19.14%
Mar 31, 2025
Gratus Capital LLC
2.11M
2.2%
+56.86K
+2.77%
Jun 30, 2024
Omega Fund Management, LLC
1.79M
1.87%
--
--
Mar 31, 2025
Adage Capital Management, L.P.
1.40M
1.46%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
976.15K
1.02%
+23.86K
+2.51%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.02%
Invesco NASDAQ Future Gen 200 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
佔比0.02%
Invesco NASDAQ Future Gen 200 ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
